...
首页> 外文期刊>Internal medicine journal >Endovascular clot retrieval for M2 segment middle cerebral artery occlusion: a systematic review and meta‐analysis
【24h】

Endovascular clot retrieval for M2 segment middle cerebral artery occlusion: a systematic review and meta‐analysis

机译:用于M2段中脑动脉闭塞的血管内凝块检索:系统评价和荟萃分析

获取原文
           

摘要

Abstract Background Endovascular clot retrieval (ECR) is the standard of care for acute ischaemic stroke due to large vessel occlusion. However, isolated occlusion of the M2 segment of the middle cerebral artery (MCA) was underrepresented in the landmark trials. Aims Given the potential treatment benefit associated with M2 MCA occlusions, we aimed to evaluate the outcome of patients undergoing ECR for M2 occlusion. Methods We conducted a systematic review and meta‐analysis of the available literature that included patients with M2 MCA occlusions who underwent ECR. Successful reperfusion was defined as a treatment in cerebral ischaemia score of 2b‐3. Good outcome was defined as a modified Rankin Scale score ≤ 2. We also analysed complications such as post‐procedure symptomatic intracranial haemorrhage and mortality at 3 months. Results Fifteen studies including 1105 patients with isolated M2 occlusions were analysed. Successful reperfusion occurred in 75.4% (95% confidence interval (CI) 67.7–84.1%) of patients; good outcome was observed in 58.3% (95% CI 51.7–63.8% of patients. The rate of symptomatic intracranial haemorrhage was 5.1% (95% CI 4.2–8.3%), and 3‐month mortality rate was 12.2% (95% CI 10.4–16.3%). Conclusion The outcomes of ECR treatment of M2 occlusions are favourable, with good safety profile. Comparison to medical management from large registries or randomised controlled trials is warranted.
机译:摘要背景血管内凝块检索(ECR)是由于大血管闭塞而导致急性缺血性脑卒中的标准。然而,中间脑动脉(MCA)的M2段的分离闭塞在地标试验中经历了代表性。鉴于与M2 MCA闭塞相关的潜在治疗益处,我们旨在评估患有M2闭塞的ECR的患者的结果。方法对可用文献进行了系统审查和荟萃分析,包括患有ECR的M2 MCA闭塞患者。成功的再灌注定义为脑缺血得分为2b-3的治疗。良好的结果被定义为改进的Rankin标准得分≤2。我们还分析了3个月后患者症状颅内出血和死亡率等并发症。结果分析了15项研究,其中包括1105例含有分离的M2闭塞患者。成功的再灌注发生在75.4%(95%置信区间(CI)67.7-84.1%);在58.3%(95%CI 51.7-63.8%的患者中,观察到良好的结果。症状颅内出血的速率为5.1%(95%CI 4.2-8.3%),3个月死亡率为12.2%(95%CI 10.4-16.3%)。结论,M2闭塞的ECR治疗结果是有利的,安全性良好。有权对大型注册管理机构或随机对照试验的医疗管理进行比较。

著录项

  • 来源
    《Internal medicine journal》 |2020年第5期|共129页
  • 作者单位

    Monash HealthMelbourne Victoria Australia;

    Interventional Neuroradiology ServiceAustin HealthMelbourne Victoria Australia;

    NeuroSpine Surgery Research GroupPrince of Wales Private HospitalSydney New South Wales Australia;

    South Australian Health and Medical Research InstituteAdelaide South Australia Australia;

    Interventional Neuroradiology ServiceAustin HealthMelbourne Victoria Australia;

    Interventional Neuroradiology UnitMonash Imaging Monash HealthMelbourne Victoria Australia;

    Stroke DivisionFlorey Institute of Neuroscience and Mental Health University of MelbourneMelbourne;

    Interventional Neuroradiology ServiceAustin HealthMelbourne Victoria Australia;

    Interventional Neuroradiology ServiceAustin HealthMelbourne Victoria Australia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内科学;
  • 关键词

    ischaemic stroke; M2; endovascular clot retrieval;

    机译:缺血性卒中;M2;血管内凝块检索;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号